Insta
J&J's Single-Dose Covid-19 Vaccine Likely To Be Imported To India By June-July: DBT Secretary Renu Swarup
(A picture of vaccine vials from Johnson and Johnson)
United States (US) based pharmaceutical major Johnson & Johnson (J&J) is working closely with Hyderabad based vaccine maker Biological E to facilitate the technology transfer for domestic manufacturing of its single-dose COVID-19 vaccine in India while it is expected that the vaccine's import into the country will begin by June-July, reports Livemint.
Sharing the development, secretary of the department of biotechnology Renu Swarup said that Biological E has an estimated capacity to produce as many as 600 million doses per annum.
Meanwhile, it should be noted that Swarup also said that Biological E is also working on its own vaccine candidate which has completed the trial stage.
Swarup further stated that the technology transfer for domestic manufacturing of the Russian Sputnik V vaccine is presently in process and that Indian production of the same will begin soon.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
